HomeIBRX • NASDAQ
add
Immunitybio Inc
Previous close
$2.19
Day range
$2.25 - $2.50
Year range
$1.83 - $4.27
Market cap
2.32B USD
Avg Volume
10.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 32.06M | 425.07% |
Operating expense | 87.51M | 1.34% |
Net income | -67.25M | 21.55% |
Net profit margin | -209.77 | 85.06% |
Earnings per share | -0.07 | 41.67% |
EBITDA | -51.68M | 31.82% |
Effective tax rate | 0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 257.81M | 97.76% |
Total assets | 518.99M | 42.36% |
Total liabilities | 1.04B | -5.98% |
Total equity | -523.41M | — |
Shares outstanding | 984.97M | — |
Price to book | -4.13 | — |
Return on assets | -30.20% | — |
Return on capital | -45.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -67.25M | 21.55% |
Cash from operations | -68.91M | 30.23% |
Cash from investing | -181.36M | -378.88% |
Cash from financing | 173.52M | 1,013.59% |
Net change in cash | -76.80M | -323.45% |
Free cash flow | -53.20M | 26.07% |
About
CEO
Founded
2014
Website
Employees
673
